Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients

Background/Objectives: Therapeutic washout protocols, where Parkinson’s disease (PD) patients discontinue their medication, are used in clinical trials to evaluate disease progression without the overt influence of symptomatic treatments. While prior washout studies focused on clinical outcomes, the participant experiences of undergoing an extended washout have not been examined. This study characterizes early-stage PD participants’ expectations, symptom experiences, emotional responses, and reflections following a one-week medication washout. Methods: Twenty early-stage PD participants enrolled in a one-week washout study (15 M/5 F; aged 65.7 ± 6.7 years; medication duration 1.8 ± 0.8 years; LEDD 490 ± 414 mg). Semi-structured interviews (~1 h) were audio-recorded, transcribed, and coded by trained coders. Transcripts were analyzed using an inductive–deductive approach to identify common themes and develop a conceptual framework. Results: All 20 participants were interviewed, including one who withdrew on day 5 due to intolerable symptoms. Recalled expectations ranged from confidence to fear of symptom exacerbation, and reassurance from study personnel reduced pre-washout anxiety. Symptoms included sleep disruption, restless legs symptoms, stiffness, tremor, and progressive motor decline that often intensified in the latter half of the week. Emotional responses ranged from frustration and isolation to equanimity. Upon resuming medications, recovery timelines varied. Many participants gained new insight into their medication’s efficacy, and some perceived their unmedicated state as a glimpse of how they might function as their disease progresses. Conclusions: This study provides the first characterization of participant experiences following a one-week medication washout in early-stage PD. These perspectives can inform washout protocol design, participant support, and retention in future clinical trials.

Authors

Institutions

Publication Details

Journal
Brain Sciences
Published
2026-11-20
DOI
https://doi.org/10.3390/brainsci16111277
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients

David Charles, David G. Schlundt, Sheffield Sharp, Mallory L. Hacker et al.
3 links
Brain Sciences
Parkinson's Disease Mechanisms and Treatments
article

Patient Perspectives Following a One-Week Medication Washout in Early-Stage Parkinson’s Disease Patients

David Charles, David G. Schlundt, Sheffield Sharp, Mallory L. Hacker, Kian Pazira, Kemberlee R. Bonnet, Leeza Kopaeva, Thomas Davis, Owen Dong, Liliana Venditti, Han Nguyen, Haley Kling, Kevin Cannard, Ella Tobias
article en

Abstract

Background/Objectives: Therapeutic washout protocols, where Parkinson’s disease (PD) patients discontinue their medication, are used in clinical trials to evaluate disease progression without the overt influence of symptomatic treatments. While prior washout studies focused on clinical outcomes, the participant experiences of undergoing an extended washout have not been examined. This study characterizes early-stage PD participants’ expectations, symptom experiences, emotional responses, and reflections following a one-week medication washout. Methods: Twenty early-stage PD participants enrolled in a one-week washout study (15 M/5 F; aged 65.7 ± 6.7 years; medication duration 1.8 ± 0.8 years; LEDD 490 ± 414 mg). Semi-structured interviews (~1 h) were audio-recorded, transcribed, and coded by trained coders. Transcripts were analyzed using an inductive–deductive approach to identify common themes and develop a conceptual framework. Results: All 20 participants were interviewed, including one who withdrew on day 5 due to intolerable symptoms. Recalled expectations ranged from confidence to fear of symptom exacerbation, and reassurance from study personnel reduced pre-washout anxiety. Symptoms included sleep disruption, restless legs symptoms, stiffness, tremor, and progressive motor decline that often intensified in the latter half of the week. Emotional responses ranged from frustration and isolation to equanimity. Upon resuming medications, recovery timelines varied. Many participants gained new insight into their medication’s efficacy, and some perceived their unmedicated state as a glimpse of how they might function as their disease progresses. Conclusions: This study provides the first characterization of participant experiences following a one-week medication washout in early-stage PD. These perspectives can inform washout protocol design, participant support, and retention in future clinical trials.

Brain SciencesVol. 16(11)
Vanderbilt University (US), Vanderbilt University Medical Center (US)
National Institutes of Health, National Institute on Aging, National Center for Advancing Translational Sciences
Good health and well-being
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon